Interleukin-10 gene expression and adult T-cell leukemia

Leuk Lymphoma. 1998 Apr;29(3-4):239-48. doi: 10.3109/10428199809068561.

Abstract

Numerous studies have shown spontaneous IL-10 gene expression and synthesis in a variety of peripheral blood or bone marrow-derived leukemic cells. These include B-cells derived from various lymphoproliferative disorders. Since little is known regarding IL-10 expression in leukemic T-cells, we examined clinical specimens of patients with adult T-cell leukemia (ATL) for IL-10 expression. Sera from ATL patients show increased levels of IL-10 when compared with sera from healthy donors. IL-10 is constitutively produced by ATL cells and also by human T-cell leukemia virus type I (HTLV-I)-infected cell lines. It is thought that HTLV-I infection induces gene expression for IL-10. In this review, a transcriptional regulation of IL-10 gene expression by HTLV-I Tax and the possible role of the NF-kappaB pathway are described.

MeSH terms

  • Gene Products, tax / physiology*
  • Humans
  • Interleukin-10 / genetics
  • Interleukin-10 / metabolism*
  • Leukemia, T-Cell / metabolism*
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / physiology
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Oligonucleotides, Antisense / pharmacology
  • Transcription Factor RelA
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Gene Products, tax
  • NF-kappa B
  • Neoplasm Proteins
  • Oligonucleotides, Antisense
  • Transcription Factor RelA
  • Interleukin-10